Consistent with the enforced expression of BCL2 and MYC, we saw strong enrichment for signatures of double hit lymphoma33,34, a subtype of lymphoma characterized by translocation of both MYC and BCL2 and associated with a particularly poor clinical outcome. The gene discussed is BCL2; the disease is lymphoma.